<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Inst Med Trop Sao Paulo</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev. Inst. Med. Trop. Sao Paulo</journal-id>
      <journal-id journal-id-type="publisher-id">rimtsp</journal-id>
      <journal-title-group>
        <journal-title>Revista do Instituto de Medicina Tropical de S&#xE3;o Paulo</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0036-4665</issn>
      <issn pub-type="epub">1678-9946</issn>
      <publisher>
        <publisher-name>Instituto de Medicina Tropical</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27007563</article-id>
      <article-id pub-id-type="pmc">4804557</article-id>
      <article-id pub-id-type="doi">10.1590/S1678-9946201658020</article-id>
      <article-id pub-id-type="other">00218</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND
RESPONSE TO TREATMENT</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>FERNANDES</surname>
            <given-names>Andrea Claudia Bekner Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>PEDROSO</surname>
            <given-names>Ra&#xED;ssa Bocchi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>VENAZZI</surname>
            <given-names>Eneide Aparecida Sabaini</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>ZANZARINI</surname>
            <given-names>Paulo Donizeti</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>ARISTIDES</surname>
            <given-names>Sandra Mara Alessi</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LONARDONI</surname>
            <given-names>Maria Valdrinez Campana</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SILVEIRA</surname>
            <given-names>Tha&#xED;s Gomes Verzignassi</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Universidade Estadual de Maring&#xE1;, Programa de P&#xF3;s-Gradua&#xE7;&#xE3;o em Ci&#xEA;ncias
da Sa&#xFA;de, Maring&#xE1;, Paran&#xE1;, Brasil. E-mails: ACBSF:
<email>acbsfernandes@gmail.com</email></aff>
      <aff id="aff2"><label>2</label>Universidade Estadual de Maring&#xE1;, Departamento de An&#xE1;lises Cl&#xED;nicas e
Biomedicina, Maring&#xE1;, Paran&#xE1;, Brasil. E-mails: EASV: <email>easvenazzi@uem.br</email></aff>
      <author-notes>
        <corresp id="c01"><bold>Correspondence to:</bold> Tha&#xED;s Gomes Verzignassi Silveira, Departamento de
An&#xE1;lises Cl&#xED;nicas e Biomedicina, Universidade Estadual de Maring&#xE1;, Av. Colombo 5790,
87020-900 Maring&#xE1;, PR, Brasil. E-mail:<email>tgvsilveira@uem.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>58</volume>
      <elocation-id>20</elocation-id>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The clinical manifestations and prognosis of cutaneous leishmaniasis (CL) can be
influenced by the immune response of the patient and the species of the parasite. A
case of atypical clinical presentation of CL, with development of non-characteristic
lesions, poor response to therapy, and a long time to resolution is reported.
Confirmatory laboratory tests included parasite detection, indirect
immunofluorescence, Montenegro skin test, polymerase chain reaction, and parasite
identification by multilocus enzyme electrophoresis. The parasite was identified as
<italic>Leishmaniabraziliensis</italic>. The lesion was unresponsive to three
complete courses of N-methylglucamine antimoniate intramuscular, and to treatment
with pentamidine. The patient did not tolerate amphotericin B. The lesion finally
receded after treatment with intravenous N-methylglucamine antimoniate. It is
essential to ensure the accuracy of diagnosis and the appropriate treatment, which
can include the use a second choice drug or a different route of administration.</p>
      </abstract>
      <kwd-group>
        <kwd>Leishmania braziliensis</kwd>
        <kwd>Cutaneous leishmaniasis</kwd>
        <kwd>Unusual clinical forms</kwd>
        <kwd>Treatment</kwd>
      </kwd-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="20"/>
        <page-count count="1"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>American cutaneous leishmaniasis (ACL) is a major public health problem in the New
World. Clinical presentation and outcome of ACL are associated with the host immune
response and the infecting <italic>Leishmania</italic> specie<xref rid="B01" ref-type="bibr">1</xref>. In Brazil, cutaneous leishmaniasis (CL), mainly caused
by<italic>Leishmania (Viannia) braziliensis</italic>, is one of the dermatological
diseases that deserves more attention due to its magnitude, as well as the risk of
deformities and psychological involvement<xref rid="B02" ref-type="bibr">2</xref>. </p>
      <p>The most common clinical form is the classical ulcer, with an indurate raised outer
border and sharply incised central crater that usually self-heals over a period of
months. The usual clinical presentations of leishmaniasis are easily diagnosed by
clinicians in endemic regions, but unusual forms may give rise to difficulties in the
diagnosis and appropriate treatment<xref rid="B02" ref-type="bibr">2</xref>. Cutaneous
leishmaniasis can produce a large variety of atypical and rare forms. There has been an
increase in the number of papers reporting unusual clinical presentations, both for the
Old and the New World<xref rid="B03" ref-type="bibr">3</xref>
<sup>,</sup>
<xref rid="B04" ref-type="bibr">4</xref>
<sup>,</sup>
<xref rid="B05" ref-type="bibr">5</xref>
<sup>,</sup>
<xref rid="B06" ref-type="bibr">6</xref>
<sup>,</sup>
<xref rid="B07" ref-type="bibr">7</xref>
<sup>,</sup>
<xref rid="B08" ref-type="bibr">8</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">9</xref>.</p>
      <p>Meglumine antimoniate is considered the first choice drug for CL treatment in Brazil.
The Ministry of Health recommends 10-20 mg/kg Sb<sup>5+</sup> per day for a period of 20
days, by intravenous or intramuscular route. If no remission is observed, a new
treatment cycle is administered for 30 days. In the absence of therapeutic response, the
second choice drugs, amphotericin B or pentamidine, are used<xref rid="B02" ref-type="bibr">2</xref>. Despite pentavalent antimonials (Sb<sup>5+)</sup> be considered
first-line drugs used to treat CL caused by different species, an increase in treatment
failure has been documented in several regions of the world<xref rid="B10" ref-type="bibr">10</xref>. </p>
      <p>We report a case of a patient with an unusual clinical form of cutaneous leishmaniasis
with poor response to antimonial therapy and development of non-characteristic lesions.
The present study received approval from the Permanent Committee for Ethics in Research
involving Humans (Process No. 533/2009) of the <italic>Universidade Estadual de
Maring&#xE1;</italic>. The patient agreed to participate in the study and signed a free
informed consent form. Written consent was obtained from the patient and his wife for
this publication.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A forty-five-year-old black male patient from
<italic>Apucarana</italic>,<italic>Paran&#xE1;</italic>, with one atypical lesion on the
right side of his back was attended, in March 2009, in the LEPAC (<italic>Laborat&#xF3;rio de
Ensino e Pesquisa em An&#xE1;lises Cl&#xED;nicas</italic>) of the <italic>Universidade Estadual
de Maring&#xE1;</italic>, for cutaneous leishmaniasis (CL) laboratory diagnosis. The
patient reported that the lesion had been present for approximately one month (<xref ref-type="fig" rid="f01">Fig. 1A</xref>). The lesion was a rounded plaque, with a
erythematous violaceous center, descamative ulcerated edges, surrounded by an extensive
area of lichenification, measuring 20 cm. Based on clinical appearance, the differential
diagnosis of the lesion included chronic simple lichen, psoriasis, squamous cell
carcinoma, chromomycosis, cutaneous tuberculosis, syphilis, paracoccidioidomycosis, and
sarcoidosis. Before seeking for medical attention, the patient used topical antibiotics,
but the lesion persisted without improvement. The performed tests showed a positive
Montenegro skin test (MST) with an induration of 10 mm and indirect immunofluorescence
(IIF) positive for anti-<italic>Leishmania</italic> IgG antibodies, reaching a titer of
80.<italic>Leishmania</italic> amastigotes were detected in the material obtained by
scraping of the lesion stained by Giemsa (<xref ref-type="fig" rid="f01">Fig. 1B</xref>)
and cultured in blood base agar (BBA). The BBA grown parasites were sent to the
<italic>Cole&#xE7;&#xE3;o de Leishmania</italic> of <italic>Instituto Oswaldo Cruz</italic>
(CLIOC), <italic>Rio de Janeiro</italic>, Brazil, for identification and the strains
were confirmed as <italic>L. (V.) braziliensis</italic> (MHOM/BR/2009/3476). The species
identification was performed by multilocus enzyme electrophoresis (MLEE). To exclude the
possibility of coexisting infections, fungi and HIV investigations were performed with
negative results. </p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><title>
<bold>-</bold> (A) Initial lesion (one-month-old) on the right back of the
patient. (B) Positive direct parasite search with characteristic amastigotes
(arrow). (C) The lesion after meglumine antimoniate (120 ampoules),
pentamidine, and amphotericin B treatments.</title></caption><graphic xlink:href="0036-4665-rimtsp-00020-gf01"/></fig>
</p>
      <p>The patient was treated with 120 ampoules of intramuscular meglumine antimoniate
(approximately 15 mg/kg Sb<sup>5+</sup> per day) in three cycles of 20 days each at the
<italic>Pronto Atendimento Municipal of Apucarana</italic> municipality.
Approximately 40 days after the end of treatment (August 2009) the lesion was still
active and new laboratory tests were performed. The IIF test was positive with a titer
of 160 and the direct parasite search was negative. </p>
      <p>About six months later (May 2010) the patient was submitted to another treatment with
intravenous pentamidine (4 mg/kg per day) for seven days, which resulted in apparent
healing of the lesion. In June 2010, the values of serum amylase (87 U/L) and creatinine
(1.0 mg/dL) were normal. However, some months later, new papular lesions emerged,
ulcerated and spread to the axillary region. In November 2010, the patient was admitted
for treatment with amphotericin B desoxycholate (50 mg/day). The treatment was
discontinued after three doses because the values of serum urea (88 mg/dL) and
creatinine (3.1 mg/dL) were increased indicating renal failure. One additional course of
pentamidine for 10 days was established (April 2011). There was a partial clinical
resolution of lesions with the patient still presenting some residual lesions. </p>
      <p>In February 2012, about three years after the onset of the lesion and despite the
multiple treatments, the lesion was not healing. The lesion was an ulcerated plaque with
erythematous fibrous bottom and verrucous edges, surrounded by a lichenification area in
the right scapular region and posterior region of the right arm (<xref ref-type="fig" rid="f01">Fig. 1C</xref>). New laboratory tests were performed. The direct parasite
search revealed the presence of characteristic amastigotes of
<italic>Leishmania</italic> spp., the IIF showed titer 320, and the polymerase chain
reaction (PCR) for kDNA minicircles of the subgenus<italic>Leishmania (Viannia)</italic>
was positive.</p>
      <p>The patient was treated again with meglumine antimoniate by the intravenous route (3
ampoules per day) for approximately 40 days. Following this treatment, the lesion
healed. Unfortunately, about a year after the end of the treatment, the patient died of
a heart attack.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>This report describes an unusual case of CL due to the clinical presentation. There was
the development of non-characteristic lesions, poor response to therapy and a long time
to resolution. The patient was referred to laboratorial diagnosis of CL because,
although he lived in an urban area, he had worked in a rural area, near a dam in an
endemic region of CL. According to the patient, the lesion had been present for
approximately one month despite presenting 20 cm. </p>
      <p>Laboratory diagnosis confirmed the clinical suspicion of CL, with positive results in
the direct search of parasites, with few amastigotes in the examined slides, presence of
IgG antibodies and positive MST. The antibody search tests are sensitive and specific,
but they are associated to cross-reactivity with other diseases, mainly Chagas disease
and visceral leishmaniasis<xref rid="B02" ref-type="bibr">2</xref>
<sup>,</sup>
<xref rid="B11" ref-type="bibr">11</xref>. MST does not differentiate current and past
disease (most often remains positive after treatment) and does not distinguish between
infection and disease. MST presents an estimated 84% positivity in the cutaneous form of
CL<xref rid="B11" ref-type="bibr">11</xref>.</p>
      <p>In the New World, about fifteen species of <italic>Leishmania</italic> were found in
humans causing CL<xref rid="B12" ref-type="bibr">12</xref>. The three main species
causing CL in Brazil are <italic>L. (V.) braziliensis</italic>, <italic>L. (V.)
guyanensis andL. (L.) amazonensis</italic>
<xref rid="B02" ref-type="bibr">2</xref>. According to WHO, the CL clinical forms
include localized, disseminated, diffuse, and atypical cutaneous and mucocutaneous
leishmaniases<xref rid="B12" ref-type="bibr">12</xref>. Many factors can influence
the clinical manifestations and prognosis of leishmaniasis, such as the immune response
of the patient and the species of the parasite<xref rid="B01" ref-type="bibr">1</xref>
<sup>,</sup>
<xref rid="B13" ref-type="bibr">13</xref>. The parasite was identified as <italic>L.
(V.) braziliensis,</italic> a prevalent species in southern Brazil and widely
distributed in the country<xref rid="B02" ref-type="bibr">2</xref>. This species can
induce a wide spectrum of clinical and immunopathological manifestations<xref rid="B14" ref-type="bibr">14</xref>. </p>
      <p>Atypical lesions of cutaneous leishmaniasis caused by different species of
<italic>Leishmania</italic> has been reported. ADRIANO <italic>et al</italic>.<xref rid="B03" ref-type="bibr">3</xref> reported a case of an unusual presentation of
American tegumentary leishmaniasis involving a solitary lesion on the ear lobe, without
ulceration. CALPOVINA <italic>et al</italic>.<xref rid="B04" ref-type="bibr">4</xref>
described three distinct variants of CL (erysipeloid, recidiva cutis (LRC), and
disseminated leishmaniasis (DL) in children, caused by <italic>L. (V.)
panamensis.</italic> TURETZ <italic>et al</italic>.<xref rid="B15" ref-type="bibr">15
</xref>described patients with disseminated leishmaniasis of acneiform, papular,
nodular, and ulcerated types, caused by <italic>L. (V.) braziliensis</italic>.
NEITZKE-ABREU <italic>et al</italic>.<xref rid="B16" ref-type="bibr">16</xref> have also
reported a case of CL with atypical clinical manifestations due to <italic>L. (V.)
braziliensis.</italic> SANDOVAL-JUAREZ <italic>et al</italic>.<xref rid="B09" ref-type="bibr">9 </xref>described an unusual clinical manifestation of CL caused by
<italic>L. amazonensis,</italic> in a child that was treated with antimony, had
partial remission of some lesions, and reactivation of the lesions following a chronic
course. </p>
      <p>In the case reported in the present study, the lesion was an atypical clinical form and
was still active after three cycles of meglumine antimoniate administered
intramuscularly. The peculiarity of this case of leishmaniasis with lesion in form of
rounded plaque, descamative ulcerated edges, erythematous violaceous center, and
presenting an extensive area of lichenification around the lesion, are uncommon clinical
manifestations in CL.</p>
      <p>In atypical cases of CL, it is important to rule out the possibility of co-infections.
CL in AIDS patients in the New World shows multiple, polymorphic and relapsing
lesions<xref rid="B12" ref-type="bibr">12</xref>. In this case, co-infection with HIV
was discarded, thereby to fungal infection.</p>
      <p>Despite the apparent healing after treatment with intravenous pentamidine, new papular
lesions emerged, ulcerated and spread to the axillary region. The patient was treated
with amphotericin B. The treatment was discontinued because the patient showed
alterations in renal function tests. An additional course of pentamidine was
administered, there was a partial clinical resolution of lesions, but some residual
lesions remained. About nine months after, the lesion was an ulcerated plaque, reaching
the right scapular region and posterior region of the right arm. Since there was no
successful treatment with second-line drugs available, meglumine antimoniate was used
again, but intravenously. Although there is no difference between the intramuscular and
intravenous routes, as regards the efficacy and safety of the drug<xref rid="B03" ref-type="bibr">3</xref>, the lesion finally receded after treatment with meglumine
antimoniate administered intravenously. </p>
      <p>Despite pentavalent antimonials (Sb<sup>5+)</sup> being considered first-line drugs used
to treat CL caused by different species, an increase in treatment failure has been
documented in several regions of the world<xref rid="B04" ref-type="bibr">4</xref>.
Studies conducted in Latin America have reported failure in CL treatment with this drug:
7% in Bolivia<xref rid="B17" ref-type="bibr">17</xref>, 16% in Brazil<xref rid="B01" ref-type="bibr">1</xref>, and up to 39% in Colombia<xref rid="B18" ref-type="bibr">18</xref>. GUIMAR&#xC3;ES <italic>et al</italic>.<xref rid="B19" ref-type="bibr">19</xref> described two cases of atypical ACL that healed after three courses of
antimony (15-20 mg/kg/day intravenously for 20 days) and 13 cases healed with
amphotericin B, after failure of three or more courses of antimony. PIMENTEL <italic>et
al.</italic>
<xref rid="B20" ref-type="bibr">20</xref> reported a similar case of cutaneous
leishmaniasis where the lesion relapsed following two systemic treatments with meglumine
antimoniate. The patient was treated with amphotericin B, which was interrupted due to
poor tolerance. Afterwards, the patient was submitted to intramuscular pentamidine, and
no relapse was observed. </p>
      <p>An atypical clinical form of CL with a difficult treatment response and a long time to
resolution was the main contribution of this study. Reports of unusual and rare clinical
forms of CL are relevant to physicians and researchers finding out
what<italic>Leishmania</italic> species are capable of, causing forms of difficult
diagnosis and treatment. Moreover, the knowledge of these cases is essential to ensure
the accuracy of diagnosis and the appropriate treatment of the patient, which can
include the use a second-line drug or a different route of administration for the
first-line drug.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grimaldi</surname>
              <given-names>G</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Tesh</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Leishmaniases of the New World: current concepts and implications for
future research</article-title>
          <source>Clin Microbiol Rev</source>
          <year>1993</year>
          <volume>6</volume>
          <fpage>230</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">8358705</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Brasil.Minist&#xE9;rio da Sa&#xFA;de</collab>
          </person-group>
          <source>Manual de Vigil&#xE2;ncia da Leishmaniose Tegumentar Americana</source>
          <edition>2</edition>
          <publisher-loc>Bras&#xED;lia</publisher-loc>
          <publisher-name>Minist&#xE9;rio da Sa&#xFA;de</publisher-name>
          <year>2013</year>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adriano</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Leal</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Breckenfield</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>American tegumentary leishmaniasis: an uncommon clinical and
histopathological presentation</article-title>
          <source>An Bras Dermatol</source>
          <year>2013</year>
          <volume>88</volume>
          <fpage>260</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="pmid">23739691</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calpovina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Uezato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nonaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hashiguchi</surname>
            </name>
          </person-group>
          <article-title>Atypical clinical variants in New World cutaneous leishmaniasis:
disseminated, erysipeloid and recidiva c&#xFA;tis due to Leishmania (V.)
panamensis</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2005</year>
          <volume>73</volume>
          <fpage>281</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="pmid">16103590</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ceyhan</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Yildirim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Basak</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Akkaya</surname>
              <given-names>VB</given-names>
            </name>
            <name>
              <surname>Erturan</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>A case of erysipeloid cutaneous leishmaniasis: atypical and unusual
clinical variant</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2008</year>
          <volume>78</volume>
          <fpage>406</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="pmid">18337335</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crowe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Slavin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stark</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Aboltins</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>A case of imported Leishmania infantum cutaneous leishmaniasis; an
unusual presentation occurring 19 years after travel</article-title>
          <source>BMC Infect Dis</source>
          <year>2014</year>
          <volume>14</volume>
          <fpage>597</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="pmid">25428722</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mings</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Beck</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ondo</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Shanler</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Berman</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis with boggy induration and simultaneous mucosal
disease</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2009</year>
          <volume>80</volume>
          <fpage>3</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">19141829</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moravvej</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Barzegar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nasiri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Abolhasani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mohebali</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis with unusual clinical and histological
presentation: report of four cases</article-title>
          <source>Acta Med Iran</source>
          <year>2013</year>
          <volume>51</volume>
          <fpage>274</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="pmid">23690110</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandoval-Juarez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Minaya-G&#xF3;mez</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rojas-Palomino</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Falconi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>C&#xE1;ceres</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Leishmaniosis cutanea: manifestaci&#xF3;n cl&#xED;nica inusual</article-title>
          <source>Rev Peru Med Exp Salud Publica</source>
          <year>2014</year>
          <volume>31</volume>
          <fpage>595</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="pmid">25418662</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lindoso</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Current diagnosis and treatment of cutaneous and mucocutaneous
leishmaniasis</article-title>
          <source>Expert Rev Anti Infect Ther</source>
          <year>2010</year>
          <volume>8</volume>
          <fpage>419</fpage>
          <lpage>433</lpage>
          <pub-id pub-id-type="pmid">20377337</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gontijo</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>MLR</given-names>
            </name>
          </person-group>
          <article-title>Leishmaniose tegumentar americana</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2003</year>
          <volume>36</volume>
          <fpage>76</fpage>
          <lpage>80</lpage>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <article-title>Control of the leishmaniasis: report of a meeting of the WHO Expert
Committee on the Control of Leishmaniases</article-title>
          <publisher-loc>Geneva</publisher-loc>
          <source>Control of the leishmaniasis: report of a meeting of the WHO Expert Committee
on the Control of Leishmaniases</source>
          <publisher-name>WHO</publisher-name>
          <comment>(Tech. Rep. Ser. no. 949)</comment>
          <year>2010</year>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Valete-Rosalino</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Pacheco</surname>
              <given-names>SJB</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>FAC</given-names>
            </name>
            <name>
              <surname>Schubach</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Pacheco</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>American tegumentary leishmaniasis caused by Leishmania (Viannia)
braziliensis: assessment of parasite genetic variability at intra- and
inter-patient levels</article-title>
          <source>Parasit Vectors</source>
          <year>2013</year>
          <volume>6</volume>
          <fpage>189</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="pmid">23786878</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silveira</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Lainson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Castro Gomes</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Laurenti</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Corbett</surname>
              <given-names>CEP</given-names>
            </name>
          </person-group>
          <article-title>Immunopathogenic competences of Leishmania (V.) braziliensis and L.
(L.) amazonensis in American cutaneous leishmaniasis</article-title>
          <source>Parasite Immunol</source>
          <year>2009</year>
          <volume>31</volume>
          <fpage>423</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">19646206</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turetz</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bittencourt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <article-title>Disseminated leishmaniasis: a new and emerging form of leishmaniasis
observed in northeastern Brazil</article-title>
          <source>J Infect Dis</source>
          <year>2002</year>
          <volume>186</volume>
          <fpage>1829</fpage>
          <lpage>1834</lpage>
          <pub-id pub-id-type="pmid">12447770</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neitzke-Abreu</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Venazzi</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Scodro</surname>
              <given-names>RBL</given-names>
            </name>
            <name>
              <surname>Zanzarini</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Fernandes</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Aristides</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis with atypical clinical manifestations: case
report</article-title>
          <source>IDCases</source>
          <year>2014</year>
          <volume>1</volume>
          <fpage>60</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">26955529</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bermudez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rojas</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Desjeux</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dujardin</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Boelaert</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Generic sodium stibogluconate is as safe and effective as branded
meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Secure
Park, Bolivia</article-title>
          <source>Ann Trop Med Parasitol</source>
          <year>2006</year>
          <volume>100</volume>
          <fpage>591</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="pmid">16989685</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palacios</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Osorio</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Grajalew</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>Treatment failure in children in a randomized clinical trial with 10
and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania
Viannia species</article-title>
          <source>Am J Trop Med Hyg</source>
          <year>2001</year>
          <volume>64</volume>
          <fpage>187</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="pmid">11442216</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guimar&#xE3;es</surname>
              <given-names>LH</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Lago</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Schriefer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bacellara</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Atypical manifestations of tegumentary leishmaniasis in a transmission
area of Leishmania braziliensis in the state of Bahia, Brazil</article-title>
          <source>Trans R Soc Trop Med Hyg</source>
          <year>2009</year>
          <volume>103</volume>
          <fpage>712</fpage>
          <lpage>715</lpage>
          <pub-id pub-id-type="pmid">19481233</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pimentel</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Baptista</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>&#xC9;F</given-names>
            </name>
            <name>
              <surname>Vasconcellos</surname>
              <given-names>&#xC9;C</given-names>
            </name>
            <name>
              <surname>Lyra</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Salgueiro</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>American cutaneous leishmaniasis caused by Leishmania (Viannia)
braziliensis resistant to meglumine antimoniate, but with good response to
pentamidine: a case report</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2011</year>
          <volume>44</volume>
          <fpage>254</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="pmid">21552747</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
